JP2006526613A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526613A5
JP2006526613A5 JP2006508431A JP2006508431A JP2006526613A5 JP 2006526613 A5 JP2006526613 A5 JP 2006526613A5 JP 2006508431 A JP2006508431 A JP 2006508431A JP 2006508431 A JP2006508431 A JP 2006508431A JP 2006526613 A5 JP2006526613 A5 JP 2006526613A5
Authority
JP
Japan
Prior art keywords
amino
propyl
aminopyridin
phenyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006508431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006526613A (ja
Filing date
Publication date
Priority claimed from GBGB0312832.9A external-priority patent/GB0312832D0/en
Application filed filed Critical
Publication of JP2006526613A publication Critical patent/JP2006526613A/ja
Publication of JP2006526613A5 publication Critical patent/JP2006526613A5/ja
Withdrawn legal-status Critical Current

Links

JP2006508431A 2003-06-04 2004-06-01 β2−アドレナリン受容体アゴニストとしての2−(6−アミノ−ピリジン−3−イル)−2−ヒドロキシエチルアミン誘導体 Withdrawn JP2006526613A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases
PCT/IB2004/001850 WO2004108676A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists

Publications (2)

Publication Number Publication Date
JP2006526613A JP2006526613A (ja) 2006-11-24
JP2006526613A5 true JP2006526613A5 (cg-RX-API-DMAC7.html) 2007-06-14

Family

ID=9959308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006508431A Withdrawn JP2006526613A (ja) 2003-06-04 2004-06-01 β2−アドレナリン受容体アゴニストとしての2−(6−アミノ−ピリジン−3−イル)−2−ヒドロキシエチルアミン誘導体

Country Status (18)

Country Link
EP (1) EP1633715B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006526613A (cg-RX-API-DMAC7.html)
AR (1) AR044475A1 (cg-RX-API-DMAC7.html)
AT (1) ATE372321T1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0410946A (cg-RX-API-DMAC7.html)
CA (1) CA2527788A1 (cg-RX-API-DMAC7.html)
CL (1) CL2004001366A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004008773T2 (cg-RX-API-DMAC7.html)
ES (1) ES2291882T3 (cg-RX-API-DMAC7.html)
GB (1) GB0312832D0 (cg-RX-API-DMAC7.html)
GT (1) GT200400116A (cg-RX-API-DMAC7.html)
MX (1) MXPA05012840A (cg-RX-API-DMAC7.html)
NL (1) NL1026329C2 (cg-RX-API-DMAC7.html)
PA (1) PA8604301A1 (cg-RX-API-DMAC7.html)
PE (1) PE20050628A1 (cg-RX-API-DMAC7.html)
TW (1) TW200524603A (cg-RX-API-DMAC7.html)
UY (1) UY28339A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004108676A1 (cg-RX-API-DMAC7.html)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
UA87854C2 (en) * 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7767677B2 (en) 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
RU2442771C2 (ru) 2005-08-08 2012-02-20 Арджента Дискавери Лтд Производные бицикло[2,2,1]гепт-7-иламина и их применения
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
EP2532677A1 (en) 2005-10-21 2012-12-12 Novartis AG Human antibodies against il13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
HRP20120494T1 (hr) 2006-04-21 2012-08-31 Novartis Ag Derivati purina za uporabu kao agonista adenozin a2a receptora
PT2035004E (pt) * 2006-06-09 2012-11-21 Parion Sciences Inc Bloqueadores dos canais de sódio de pirazinoilguanidona substituída com fenilo que possuem actividade agonista beta
JP5483880B2 (ja) 2006-10-23 2014-05-07 武田薬品工業株式会社 イミノピリジン誘導体およびその用途
EP2332933A1 (en) 2007-05-07 2011-06-15 Novartis AG Epithelial sodium channel (ENaC) inhibitors
BRPI0820669A2 (pt) 2007-12-10 2020-08-04 Novartis Ag compostos orgânicos
JP5584138B2 (ja) 2008-01-11 2014-09-03 ノバルティス アーゲー キナーゼ阻害剤としてのピリミジン類
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
KR20110040818A (ko) 2008-06-10 2011-04-20 노파르티스 아게 상피 나트륨 채널 차단제로서의 피라진 유도체
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
DE102008049675A1 (de) 2008-09-30 2010-04-01 Markus Dr. Heinrich Verfahren zur Herstellung von 3-Aminobiphenylen
PL2379507T3 (pl) 2008-12-30 2014-03-31 Pulmagen Therapeutics Inflammation Ltd Związki sulfonamidu do leczenia zaburzeń układu oddechowego
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
AU2010310449A1 (en) 2009-10-22 2012-05-03 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
CN103946221B (zh) 2011-09-16 2016-08-03 诺华股份有限公司 用于治疗囊性纤维化的杂环化合物
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
JP6165733B2 (ja) 2011-09-16 2017-07-19 ノバルティス アーゲー N−置換ヘテロシクリルカルボキサミド類
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
AU2014391610B2 (en) 2014-04-24 2018-01-25 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
KR20160145780A (ko) 2014-04-24 2016-12-20 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피리딘 유도체
CA2945212A1 (en) 2014-04-24 2015-10-29 Novartis Ag Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
US20200383960A1 (en) 2019-06-10 2020-12-10 Novartis Ag Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis
KR20220052934A (ko) 2019-08-28 2022-04-28 노파르티스 아게 치환 1,3-페닐 헤테로아릴 유도체 및 질환 치료에서의 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPH11504649A (ja) * 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β−アドレナリン作働性アゴニスト
DE60015036T2 (de) * 1999-07-23 2006-03-02 Pfizer Products Inc., Groton Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
MXPA05003866A (es) * 2002-10-11 2005-06-22 Pfizer Derivados de indol como agonistas beta-2.

Similar Documents

Publication Publication Date Title
JP2006511596A5 (cg-RX-API-DMAC7.html)
ES2291882T3 (es) Derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de adrenoceptores beta 2.
CA2499314A1 (en) Indole derivatives as beta-2 agonists
CA2553789A1 (en) Sulfonamide derivatives for the treatment of diseases
JP2009530364A5 (cg-RX-API-DMAC7.html)
KR100749990B1 (ko) 베타2 효능제로서의(2-히드록시-2-(4-히드록시-3-히드록시메틸페닐)-에틸아미노)-프로필 페닐 유도체
SI3097086T1 (en) (2S) -N - ((1S) -1-cyano-2-phenylethyl) -1,4-oxazepane-2-carboxamides as the dipeptidyl
US7268147B2 (en) Compounds useful for the treatment of diseases
RU2009118825A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2008512470A5 (cg-RX-API-DMAC7.html)
CN1466569A (zh) 新型3-取代的脲衍生物及其药学应用
JP2007529499A5 (cg-RX-API-DMAC7.html)
JP4054366B2 (ja) 疾患の治療のために有用な化合物
CN1942432A (zh) 作为β-2-激动剂的苯乙醇胺衍生物
CA2539070A1 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
WO2009034432A2 (en) Novel compounds active as muscarinic receptor antagonists
JP4819770B2 (ja) アドレナリン受容体として有用なホルムアミド誘導体
TH79571A (th) อนุพันธ์ฟอร์แมมีดสำหรับรักษาโรค
TH81542A (th) การใช้ประโยชน์สารประกอบสำหรับการรักษาของโรค
JP2008056680A5 (cg-RX-API-DMAC7.html)
TH68217A (th) อนุพันธ์อินโดลที่เป็นประโยชน์สำหรับรักษาโรค
CN1934104A (zh) 用于治疗疾病的化合物
HK1096379A1 (zh) 用於治疗疾病的磺酰胺衍生物
HK1089097A (en) '(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
CN1934071A (zh) 可用作肾上腺素能受体的甲酰胺衍生物